LACTOLOGY FOUNDATION

Liquid paraffin combinations (ATC A06AA51) are emollient laxative preparations in which liquid paraffin is combined with other agents (most often magnesium hydroxide or similar) and are used for short‑term relief of constipation, including in patients who may be breastfeeding. From a toxicological‑lactational perspective they are generally low‑risk when used briefly at recommended doses, but chronic use and paraffin exposure from breast creams can markedly increase infant mineral paraffin intake and should be avoided or minimized.medpedia.framar+5

ATC class and composition

ATC code A06AA51 designates “liquid paraffin, combinations”, within emollient laxatives used for disorders of the gastrointestinal tract (constipation). These medicines typically contain paraffinum liquidum (highly refined mineral oil) together with other laxatives such as magnesium hydroxide or milk of magnesia to enhance stool softening and lubricating effects. Liquid paraffin itself is a mixture of saturated hydrocarbons derived from petroleum, refined to pharmaceutical grade and widely used both as a laxative and as an emollient in topical products.e-lactancia+5

Mechanism of action

Liquid paraffin acts in the intestinal lumen as a non‑absorbable lubricant and stool softener, coating the fecal mass and the mucosa and allowing water retention in stool. In combination products, the added components (for example magnesium hydroxide) exert osmotic or antacid actions that further increase stool water content and facilitate defecation. The onset of laxative action is typically within hours, and paraffin is not significantly absorbed systemically under normal use, which limits classical systemic toxicity but not local or aspiration‑related risks.truemeds+4

Indications and clinical use

Liquid paraffin combinations are used for symptomatic treatment of constipation, particularly in chronic or difficult cases where softer stools and reduced straining are desired. They are recommended for short‑term or occasional use; prolonged treatment can lead to dependence and reduced normal colonic motility. In practice they may also be used in patients who should avoid strong stimulant laxatives (e.g. some postoperative or postpartum patients), but this should be individualized by the prescriber.rxwiki+6

Contraindications and precautions

Liquid paraffin combinations are contraindicated in patients with hypersensitivity to paraffin or to any excipient, in children below a certain age (often <6 years), and in adults with severe chronic illness because of the risk of lipid pneumonia if paraffin is aspirated. Use is generally discouraged in patients with swallowing difficulties, gastro‑oesophageal reflux, or high aspiration risk, and in prolonged bed rest, because silent aspiration of oil may occur. Chronic daily use should be avoided due to the risk of impaired absorption of fat‑soluble vitamins and interactions with some orally administered medicines.hpra+4

Dosage and administration

Administration is oral, usually once daily, often at bedtime or before breakfast to facilitate morning defecation. Adult doses of liquid paraffin (alone or in combinations) commonly range around 15–30 ml or 20–40 ml per day, with lower volumes for older children when such use is permitted, and treatment duration is generally limited to a few days. When given together with other oral medicines, an interval of several hours is recommended to reduce interference with absorption of concomitant drugs and nutrients.greenbook.nafdac+5

Adverse effects and toxicity profile

Common adverse effects include abdominal discomfort, nausea, vomiting and oily rectal leakage, which can cause anal irritation, pruritus ani and soiling. Long‑term use may lead to decreased intestinal motility, laxative dependence, reduced absorption of fat‑soluble vitamins (A, D, E, K) and diminished bioavailability of some orally administered drugs. A serious but rare toxicological risk is lipid pneumonia resulting from aspiration of paraffin, especially in frail, elderly or neurologically impaired patients; therefore careful patient selection and avoidance in high‑risk groups is important.doctoroncall+4

Drug interactions and nutrient interference

Liquid paraffin can delay or reduce absorption of fat‑soluble vitamins due to its presence in the intestinal lumen and its interference with micelle formation. It may also affect the absorption and effect of certain oral medicines, including potassium‑sparing diuretics, if taken concurrently, so spacing of doses and medical review of drug regimens are recommended. In lactating women, reduced maternal vitamin status from chronic paraffin use could theoretically contribute to lower transfer of fat‑soluble vitamins into breast milk, although this is less clinically documented than the direct paraffin exposure discussed below.pubmed.ncbi.nlm.nih+3

Lactation safety assessment

E‑lactancia and other lactation resources consider mineral oil used as an oral laxative to be compatible with breastfeeding and “not risky” for the infant when used appropriately, acknowledging its widespread use without reported serious harm. However, repeated or chronic use of liquid paraffin during lactation may reduce maternal absorption of nutrients and some medications, and this, together with potential transfer of low‑molecular‑weight paraffins into milk, supports a cautious, short‑term use approach. Overall, brief, intermittent use of A06AA51 products at recommended doses in otherwise healthy breastfeeding women appears acceptable, but safer alternatives should be preferred for long‑term management of constipation.e-lactation+3

Infant exposure via breast milk and dermal products

Studies have demonstrated that mineral C15–C45 paraffins are detectable in human milk, with mean concentrations around 95 mg/kg fat and maxima up to 1300 mg/kg, reflecting environmental and product‑related exposure. Paraffin‑containing breast creams can significantly increase paraffin concentrations in breast milk, leading lactation experts to recommend avoiding such creams or minimizing their use on the breast and ensuring residues are removed before the next feed. In worst‑case scenarios, infant daily intake from licking off breast care products has been estimated at tens of mg/kg body weight, exceeding provisional acceptable daily intakes, so combined exposure from oral maternal laxatives plus topical breast products warrants particular attention.e-lactation+1

Risk mitigation strategies in breastfeeding

For breastfeeding women requiring constipation treatment, non‑paraffin laxatives with better established safety (e.g. bulk‑forming agents or certain osmotic laxatives) should generally be considered first line. If an A06AA51 liquid paraffin combination is used, the course should be short, the lowest effective dose should be chosen, and concurrent use of paraffin‑rich breast care creams should be avoided or minimized with thorough cleansing before feeds. Clinicians should monitor for maternal gastrointestinal side effects, signs of malabsorption or aspiration risk, and in infants for unusual gastrointestinal symptoms or excessive exposure from dermal products.medpedia.framar+3

Regulatory and access considerations

Liquid paraffin combinations in the A06AA51 group are often available without prescription in community pharmacies and are widely used as over‑the‑counter laxatives. Despite their non‑prescription status, professional counseling is recommended in pregnant and lactating women, in patients on multiple medications, and in those with significant comorbidity, to minimize toxicological and nutritional risks. Product‑specific summaries of product characteristics from national agencies should be consulted for exact composition, dosing and contraindications, as these may vary across markets.afya-pharmacy+7